TNF and Parkinson disease: Current increase in plasma IL-1β, IL-2, TNF-α, and IFN-γ in PD patients is consistent with the previous findings in spinal cerebrospinal fluid and postmortem brain (Nagatsu et al., 2000; Qin et al., 2016).